Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Recruiting 2Active not recruiting 1

Sponsor Class

OTHER 3

Study Type

Observational 2Interventional 1

Sponsor

Cancer Type

Thoracic 8Other hematologic neoplasm 6Gastrointestinal 6Breast 5Other solid neoplasm 4Lymphoid 4Genitourinary 4Gynecologic 3Plasma cell 2Other 2Other neoplasm 1Myeloid 1Dermatologic 1

Conditions

Pelvic Neoplasms 1Malignant Primary Pelvic Neoplasm 1FIGO Grade 1 Endometrial Endometrioid Adenocarcinoma 1

Interventions

Paclitaxel 140pembrolizumab 119Carboplatin 104Bevacizumab 90Cisplatin 67Specimen Handling 62Magnetic Resonance Spectroscopy 51olaparib 50Gemcitabine 39Nivolumab 36Biopsy 36liposomal doxorubicin 32Taxes 31Cyclophosphamide 31Blood Specimen Collection 29niraparib 27lenvatinib 26Letrozole 26Doxorubicin 26Topotecan 25Drug Therapy 25Immunoglobulin G 22fludarabine 21atezolizumab 21Radiotherapy 21Brachytherapy 21Disulfides 20durvalumab 19Surveys and Questionnaires 19dostarlimab 18

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Exercise Test × Gynecologic × 1 year × Clear all
NCT05134142 2026-05-20

Quality of Life and Function of Patients With Pelvic Tumors After Undergoing Hemipelvectomy

M.D. Anderson Cancer Center

Recruiting
200 enrolled
Gynecologic

Malignant Primary Pelvic Neoplasm

NCT06213571 2026-01-09

Remote Home-Based Exercise Program for Strength Training in Endometrial Cancer Survivors in Rural Areas

Mayo Clinic

Phase NA Active not recruiting
80 enrolled
Gynecologic

FIGO Grade 1 Endometrial Endometrioid Adenocarcinoma

NCT00493688 2026-01-08

A Study to Determine Whether Perioperative Energy Dynamics Correlates With Postoperative Outcomes

M.D. Anderson Cancer Center

Recruiting
200 enrolled
Gynecologic

Pelvic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡